Cytochrome P450 and its interactions with the heme biosynthetic pathway

Canadian Journal of Physiology and Pharmacology

Volumn 74, Issue 1, 1996, Pages 1-8

  De Matteis, Francesco ^a   Marks, Gerald S ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

Ascorbate; Cytochrome P450; Heme; N alkylporphyrins; Porphyria

Indexed keywords

ANDROSTENEDIONE HYDROXYLASE; ASCORBIC ACID; CYTOCHROME P450; GRISEOFULVIN; LIVER ENZYME; PORPHYRIN; PORPHYRINOGEN; PROGESTERONE HYDROXYLASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BIRD; CHICKEN; CONFERENCE PAPER; CONTROLLED STUDY; EMBRYO; HEME SYNTHESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029873802     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y95-234     Document Type: Conference Paper

References (60)

1. Billi, S.C., De Calmanovich, W., and San Martin De Viale, L.C. 1986. Rat liver porphyrinogen carboxylase inhibitor as a function of the degree of hexachlorobenzene-induced porphyria. In Heachlorobenzene: Proceedings of an International Symposium. Edited by C.R. Morris and J.R.D. Cabrai. IARC Sci. Publ. 77: 487-491.
2. Brady, A.M., and Lock, E.A. 1992. Inhibition of ferrochelatase and accumulation of porphyrins in mouse hepatocyte cultures exposed to porphyrinogenic chemicals. Arch. Toxicol. 66: 175-181.
3. Cantoni, L., Dal Fiume, D., Rizzardini, M., and Ruggieri, R. 1984. In vitro inhibitory effect on porphyrinogen carboxy-lyase of liver extracts from TCDD treated mice. Toxicol. Lett. 20: 211-217.
4. Cole, S.P.C., Zelt, D.T., and Marks, G.S. 1981. Comparison of the effects of griseofulvin and 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on ferrochelatase activity in chick embryo liver. Mol. Pharmacol. 19: 477-480.
5. Correia, M.A., Decker, C., Sugiyama, K., Caldera, P., Bornheim, L., Wrighton, S.A., Rettie, A.E., and Trager, W.F. 1987. Degradation of rat hepatic cytochrome P-450 heme by 3,5-dicarbethoxy-2,6-dimethyl-4-ethyl-1,4-dihydropyridine to irreversibly bound protein adducts. Arch. Biochem. Biophys. 258: 436-451.
6. Correia, M.A., Sugiyama, K., and Yao, K. 1989. Degradation of rat hepatic cytochrome P-450p. Drug Metab. Rev. 20: 615-628.
7. Correia, M.A., Yao, K., Wrighton, S.A., Waxman, D.J., and Rettie, A.E. 1992. Differential apoprotein loss of rat liver cytochromes P450 after their inactivation by 3,5-dicarbethoxy-2,6-dimethyl-1,4-dihydropyridine: a case for distinct proteolytic mechanisms? Arch. Biochem. Biophys. 294: 493-503.
8. De Matteis, F. 1978. Loss of liver cytochrome P-450 caused by chemicals. Damage to the apoprotein and degradation of the heme moiety. In Handbook of experimental pharmacology. Edited by F. De Matteis and W.N. Aldridge. Springer-Verlag, Berlin, pp. 95-127.
9. De Matteis, F. 1988. Role of iron in the hydrogen peroxide-dependent oxidation of hexahydroporphyrins (porphyrinogens): a possible mechanism for the exacerbation by iron of hepatic uroporphyria. Mol. Pharmacol. 33: 463-469.
10. De Matteis, F., and Stonard, M. 1977. Experimental porphyrias as models for human hepatic porphyrias. Semin. Hematol. 14: 187-192.
11. De Matteis, F., Abritti, G., and Gibbs, A.H. 1973. Decreased liver activity of porphyrin-metal chelatase in hepatic porphyria caused by 3,5-diethoxycarbonyl-1,4-dihydrocollidine. Biochem. J. 134: 717-727.
12. De Matteis, F., Gibbs, A.M., and Smith, A.G. 1980. Inhibition of protohaem ferro-lyase by N-substituted porphyrins. Structural requirements for the inhibitory effect. Biochem. J. 189: 645-651.
13. De Matteis, F., Harvey, C., and Martin, S.R. 1986. N-Alkylation of exogenous haem analogues caused by drugs in isolated hepatocytes. Structural isomerism and chirality of the resulting porphyrins. Biochem. J. 238: 263-268.
14. De Matteis, F., Harvey, C., Reed, C., and Hempenius, R. 1988. Increased oxidation of uroporphyrinogen by an inducible liver microsomal system. Possible relevance to drug-induced uroporphyria. Biochem. J. 250: 161-169.
15. De Matteis, F., Gibbs, A.H., Martin, S.R., and Milek, L.B. 1991. Labelling in vivo and chirality of griseofulvin-derived N-alkylated protoporphyrins. Biochem. J. 280: 813-816.
16. De Verneuil, H., Sassa, S., and Kappas, A. 1983. Effects of polychlorinated biphenyl compounds, 2,3,7,8-tetrachlorodibenzo-p-dioxin and iron on hepatic uroporphyrinogen decarboxylase. Biochem. J. 214: 145-151.
17. Elder, G.H. 1978. Porphyria caused by hexachlorobenzene and other polyhalogenated aromatic hydrocarbons. In Heme and hemoproteins. Handbook of experimental pharmacology. Vol. 44. Edited by F. De Matteis and W.N. Aldridge. Springer-Verlag, Berlin, pp. 157-200.
18. Farrell, G.C., and Correia, M.A. 1980. Structural and functional reconstitution of hepatic cytochrome P-450 in vivo. Reversal of allylisopropylacetamide-mediated destruction of the hemoprotein by exogeous heme. J. Biol. Chem. 255: 10 128-10 133.
19. Ferioli, A., Harvey, C., and De Matteis, F. 1984. Drug-induced accumulation of uroporphyrin in chicken hepatocyte cultures. Structural requirements for the effect and role of exogenous iron. Biochem. J. 224: 769-777.
20. Frater, Y., Brady, A., Lock, E.A., and De Matteis, F. 1993. Formation of N-methyl protoporphyrin in chemically-induced protoporphyria. Studies with a novel porphyrinogenic agent. Arch. Toxicol. 67: 179-185.
21. Gonzalez, F.J. 1992. Human cytochromes P450: problems and prospects. Trends Pharmacol. Sci. 13: 346-352.
22. Halpert, J., Jaw, J.-Y., Cornfield, L.J., Balfour, C., and Mash, E.A. 1989. Selective inactivation of rat liver cytochromes P-450 by 21-chlorinated steroids. Drug Metab. Dispos. 17: 26-31.
23. Hamilton, J.W., Bement, W.J., Sinclair, P.R., Sinclair, J.F., and Wetterhahn, K.E. 1988. Expression of 5-aminolevulinate synthase and cytochrome P-450 mRNAs in chicken embryo hepatocytes in vivo and in culture. Effect of porphyrinogenic drugs and haem. Biochem. J. 255: 267-275.
24. Heikel, T., Lockwood, W., and Rimington, C. 1958. Formation of nonenzymic haem. Nature (London), 182: 313.
25. Holley, A.E., Frater, Y., Gibbs, A.H., De Matteis, F., Lamb, J.H., Farmer, P.B., and Naylor, S. 1991. Isolation of two N-monosubstituted protoporphyrins, bearing either the whole drug or a methyl group on the pyrrole nitrogen atom, from liver of mice given griseofulvin. Biochem. J. 274: 843-848.
26. Jacobs, J.M., Sinclair, P.R., Bement, W.J., Lambrecht, R.W., Sinclair, J.F., and Goldstein, J.A. 1989. Oxidation of uroporphyrinogen by methylcholanthrene-induced cytochrome P-450. Essential role of cytochrome P-450d. Biochem. J. 258: 247-253.
27. James, C.A., and Marks, G.S. 1989. Inhibition of chick embryo hepatic uroporphyrinogen decarboxylase by components of xenobiotic-treated chick embryo hepatocytes in culture. Can. J. Physiol. Pharmacol. 67: 246-249.
28. Kimmett, S.M., McNamee, J.P., and Marks, G.S. 1994. Mechanism-based inactivation of hepatic cytochrome P450 2C6 and P450 3A1 following in vivo administration of 3,5-diethoxycarbonyl-1,4-dihydro-2,6-dimethyl-4-ethylpyridine to rats: differences from previously observed in vitro results. Can. J. Physiol. Pharmacol. 72:397-401.
29. Lambrecht, R.W., Sinclair, P.R., Gorman, N., and Sinclair, J.F. 1992. Uroporphyrinogen oxidation catalyzed by reconstituted cytochrome P450 1A2. Arch. Biochem. Biophys. 294: 504-510.
30. Lindberg, R.L.P., Porcher, C., Ledermann, B., Grandchamp, B., Burki, K., and Meyer, U.A. 1994. The heme-deficient mouse - a tool to study heme proteins and an animal model for human porphyria. In Proceedings of 10th International Symposium on Microsomes and Drug Oxidations, Toronto, Ont., July 18-21, 1994. p. 531.
31. Lukton, D., Mackie, J.E., Lee, J.S., Marks, G.S., and Ortiz de Montellano, P.R. 1988. 2,2-Dialkyl-1,2-dihydroquinolines: cytochrome P-450 catalyzed N-alkylprotoporphyrin formation, ferrochelatase inhibition, and induction of 5-aminolevulinic acid synthase activity. Chem. Res. Toxicol. 1: 208-215.
32. 1 P450 messenger RNA levels by dihydropyridines, dihydroquinolines, sydnones, and N-ethylprotoporphyrin IX. Biochem. Pharmacol. 42: 475-483.
33. Marks, G.S. 1978. The effects of chemicals on hepatic heme biosynthesis. In Handbook of experimental pharmacology. Edited by F. De Matteis and W.N. Aldridge. Springer-Verlag, Berlin, pp. 201-237.
34. Marks, G.S., Powles, J., Lyon, M., McCluskey, S., Sutherland, E., and Zelt, D. 1987. Patterns of porphyrin accumulation in response to xenobiotics. Parallels between results in chick embryos and rodents. Ann. N.Y. Acad. Sci. 514: 113-127.
35. Marks, G.S., McCluskey, S.A., Mackie, J.E., Riddick, D.S., and James, C.E. 1988. Disruption of hepatic heme biosynthesis after interaction of xenobiotics with cytochrome P-450. FASEB J. 2: 2774-2783.
36. Mukerji, S., Pimstone, N., and Burns, M. 1984. Dual mechanism of inhibition of rat liver uroporphyrinogen decarboxylase activity by ferrous iron: its potential role in the genesis of porphyria cutanea tarda. Gastroenterology, 87: 1248-1254.
37. Murray, M. 1992. P450 enzymes. Inhibition mechanisms, genetic regulation and effects of liver disease. Clin. Pharmacokinet. 23: 132-146.
38. Onisawa, J., and Labbe, R.F. 1963. Effects of diethyl-1,4-dihydro-2,4,6-trimethylpyridine-3,5-dicarboxylate on the metabolism of porphyrins and iron. J. Biol. Chem. 238: 724-727.
39. Ortiz de Montellano, P.R., and Correia, M. A. 1983. Suicidal destruction of cytochrome P-450 during oxidative drug metabolism. Annu. Rev. Pharmacol. Toxicol. 23: 481-503.
40. Ortiz de Montellano, P.R., and Mico, B.A. 1980. Destruction of cytochrome P-450 by ethylene and other olefins. Mol. Pharmacol. 18: 128-135.
41. Ortiz de Montellano, P.R., Mico, B., and Yost, G.S. 1978. Suicidal inactivation of cytochrome P-450. Formation of a heme-substrate covalent adduct. Biochem. Biophys. Res. Commun. 83: 132-137.
42. Ortiz de Montellano, P.R., Beilan, H.S., and Kunze, K.L. 1981. N-Methylprotoporphyrin IX: chemical synthesis and identification as the green pigment produced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine treatment. Proc. Natl. Acad. Sci. U.S.A. 78: 1490-1494.
43. Ortiz de Montellano, P.R., Costa, A.K., Grab, L.A., Sutherland, E.P., and Marks, G.S. 1985. Cytochrome P-450 destruction and ferrochelatase inhibition. In Porphyrins and porphyrias. Edited by Y. Nordmann. John Libbey Eurotext, INSERM, London, pp. 109-117.
44. Riddick, D.S., Park, S.S., Gelboin, H.V., and Marks, G.S. 1989. Effects of 4-alkyl analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on the major inducible cytochrome P-450 isozymes of rat liver. Mol. Pharmacol. 35: 626-634.
45. Riddick, D.S., McGilvray, I., and Marks, G.S. 1990a. Inactivation of rat liver microsomal steroid hydroxylations by 4-alkyl analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine: evidence for selectivity among steroid-inducible cytochrome P450IIIA forms. Can. J. Physiol. Pharmacol. 68: 1533-1541.
46. Riddick, D.S., Park, S.S., Gelboin, H.V., and Marks, G.S. 1990b. Effects of 4-alkyl analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on hepatic cytochrome P-450 heme, apoproteins, and catalytic activities following in vivo administration to rats. Mol. Pharmacol. 37: 130-136.
47. Rifkind, A.B. 1979. Maintenance of microsomal hemoprotein concentration following inhibition of ferrochelatase activity by 3,5-diethoxycarbonyl-1,4-dihydrocollidine in chick embryo liver. J. Biol. Chem. 254: 4636-4644.
48. Sadano, H., and Omura, T. 1985. Incorporation of heme to microsomal cytochrome P-450 in the absence of protein biosynthesis. J. Biochem. 98: 1321-1331.
49. Sardana, M.K., Rajamanickam, C., and Padmanaban, G. 1976. Differential role of heme in the synthesis of mitochondrial and microsomal hemoproteins. In Porphyrins in human diseases. Edited by M. Doss. Karger, Basel, pp. 62-70.
50. Sinclair, P.R., Lambrecht, R., and Sinclair, J. 1987. Evidence for cytochrome P450-mediated oxidation of uroporphyrinogen by cell-free extracts from chick embryos treated with 3-methylcholanthrene. Biochem. Biophys. Res. Commun. 146: 1324-1329.
51. Smith, A.G., and Francis, J.E. 1987. Chemically induced formation of an inhibitor of hepatic uroporphyrinogen decarboxylase in inbred mice with an iron overload. Biochem. J. 246: 221-226.
52. Smith, A.G., Cabrai, J.R.P., and De Matteis, F. 1979. A difference between two strains of rats in their liver non-haem iron content and in their response to the porphyrinogenic effect of hexachlorobenzene. Chem.-Biol. Interact. 27: 353-363.
53. Smith, D.A. 1991. Species differences in metabolism and pharmacokinetics: are we close to an understanding? Drug Metab. Rev. 23: 355-373.
54. Srivastava, G., Borthwick, I.A., Maguire, D.J., Elferink, C.J., Bawdin, M.J., Mercer, J.F., and May, B.K. 1988. Regulation of 5-aminolevulinate synthase mRNA in different rat tissues. J. Biol. Chem. 263: 5202-5209.
55. Sweeney, G.D. 1986. Porphyria cutanea tarda, or the uroporphyrinogen decarboxylase deficiency diseases. Clin. Biochem. 19: 3-15.
56. Tephly, T.R., Gibbs, A.H., and De Matteis, F. 1979. Studies on the mechanism of experimental porphyria produced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine. Role of a porphyrin-like inhibitor of protohaem ferro-lyase. Biochem. J. 180: 241-244.
57. Tephly, T.R., Black, K.A., Green, M.D., Coffman, B.L., Dannan, G.A., and Guengerich, F.P. 1986. Effect of the suicide substrate 3,5-diethoxycarbonyl-2,6-dimethyl-4-ethyl-1,4-dihydropyridine on the metabolism of xenobiotics and on cytochrome P-450 apoproteins. Mol. Pharmacol. 29:81-87.
58. Upadhya, P., Venkateswara Rao, M., Venkateswar, V., Rangarajan, P.N., and Padmanaban, G. 1992. Identification and functional characterization of a cis-acting positive DNA element regulating CYP 2B1/B2 gene transcription in rat liver. Nucleic Acids Res. 20: 557-562.
59. Waxman, D.J. 1991. P450-catalyzed steroid hydroxylation: assay and product identification by thin-layer chromatography. Methods Enzymol. 206: 462-476.
60. Wrighton, S.A., and Stevens, J.C. 1992. The human hepatic cytochromes P450 involved in drug metabolism. Crit. Rev. Toxicol. 22(1): 1-21.